Dr Boreham's Crucible: Imugene - FNArena.com : vimarsana.com

Tim Boreham highlights the prospects for cancer treatment biotech Imugene

Related Keywords

Vienna , Wien , Austria , North Carolina , United States , Phoenix , Arizona , Blackrock , South Australia , Australia , Nicholas Smith , Lesley Russell , Kim Drapkin , Tim Boreham , Jennifer Chow , Jakob Dupont , Leslie Chong , Jens Eckstein , Michael Amoroso , Yuman Fong , Paul Hopper , Banner Health , Vanguard Group Inc , Ohio State University , Blackrock Inc , Genentech , Kite Pharmaceuticals , University Of Vienna , Small Caps , Vanguard Group , Mann Family , Nasdaq Listed Precision , Biolife Science Queensland , Medical University , Prof Yuman , Prof Fong , Precision Biosciences ,